Imunon, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Imunon, Inc. (IMNN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $1.76 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-14
- Imunon, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $100.00K.
- Imunon, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $1.66M, a 84.61% decline year-over-year.
- Imunon, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$2.18M.
- Imunon, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $10.78M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month |
|---|---|---|
| 2017-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.76M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.66M 10-Q · filed 2017-05-12 | |
| 2016-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $8.60M 10-Q · filed 2017-08-14 |
| 2016-03-31 | $10.78M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |